+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

ePRO, E-Patient Diaries and eCOA - Global Market Trajectory & Analytics

  • PDF Icon

    Report

  • 360 Pages
  • July 2022
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 5139503

Global ePRO, E-Patient Diaries and eCOA Market to Reach $3.2 Billion by 2027

Amid the COVID-19 crisis, the global market for ePRO, E-Patient Diaries and eCOA estimated at US$1.3 Billion in the year 2020, is projected to reach a revised size of US$3.2 Billion by 2027, growing at a CAGR of 13.9% over the period 2020-2027. eClinical Outcome Assessments (eCOAs), one of the segments analyzed in the report, is projected to record a 14.2% CAGR and reach US$962.5 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Epatient Reported Outcomes (epros) segment is readjusted to a revised 15.5% CAGR for the next 7-year period.

The U.S. Market is Estimated at $454.8 Million, While China is Forecast to Grow at 16.9% CAGR

The ePRO, E-Patient Diaries and eCOA market in the U.S. is estimated at US$454.8 Million in the year 2020. China, the world's second largest economy, is forecast to reach a projected market size of US$379.5 Million by the year 2027 trailing a CAGR of 16.9% over the period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 11.4% and 13.3% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 12.3% CAGR.

Clinician Reported Outcomes (ClinROs) Segment to Record 12.9% CAGR

In the global Clinician Reported Outcomes (ClinROs) segment, USA, Canada, Japan, China and Europe will drive the 12.9% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$186.3 Million in the year 2020 will reach a projected size of US$422.9 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets.

Select Competitors (Total 75 Featured)

  • Anju Software, Inc.
  • ArisGlobal LLC
  • Castor EDC
  • Clario
  • Climedo Health GmbH
  • ClinCapture
  • Dassault Systèmes SE
  • eClinical Solutions LLC
  • ICON plc
  • IQVIA Holdings, Inc.
  • Kayentis, SAS
  • Medidata Solutions Inc.
  • Mednet
  • Signant Health
  • TransPerfect

What's New for 2022?

  • Global competitiveness and key competitor percentage market shares
  • Market presence across multiple geographies - Strong/Active/Niche/Trivial
  • Online interactive peer-to-peer collaborative bespoke updates
  • Access to a digital archives and Research Platform
  • Complimentary updates for one year
Frequently Asked Questions about the Global Market for ePRO, E-Patient Diaries and eCOA

What is the estimated value of the Global Market for ePRO, E-Patient Diaries and eCOA?

The Global Market for ePRO, E-Patient Diaries and eCOA was estimated to be valued at $1.3 Billion in 2020.

What is the growth rate of the Global Market for ePRO, E-Patient Diaries and eCOA?

The growth rate of the Global Market for ePRO, E-Patient Diaries and eCOA is 13.7%, with an estimated value of $3.2 Billion by 2027.

What is the forecasted size of the Global Market for ePRO, E-Patient Diaries and eCOA?

The Global Market for ePRO, E-Patient Diaries and eCOA is estimated to be worth $3.2 Billion by 2027.

Who are the key companies in the Global Market for ePRO, E-Patient Diaries and eCOA?

Key companies in the Global Market for ePRO, E-Patient Diaries and eCOA include Anju Software, Inc., ArisGlobal LLC, Castor EDC, Clario, Climedo Health GmbH, ClinCapture, Dassault Systèmes SE, eClinical Solutions LLC and IQVIA Holdings, Inc..

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Impact of COVID-19 Pandemic and Looming Global Recession
  • Year 2021 in Review and Near-term Outlook
  • Prolonged Pandemic, Ukraine-Russia Conflict and Ensuing Economic Disruptions Impact Growth Outlook
  • Exhibit 1: World Economic Growth Projections (Real GDP, Annual % Change) for the Years 2021, 2022 and 2023
  • Pandemic Jolt Brings Strategic & Lasting Changes to Healthcare Sector
  • COVID-19 Expedites Healthcare Ecosystem's Evolution for Better Care & Cost Savings
  • The Adoption of Telemedicine Services Accelerates Amidst the Pandemic
  • Exhibit 2: Telemedicine Leads Digital Health Investments Driven by COVID-19: Leading Categories of Digital Health by Funding (In US$ Billion) for the Year 2020
  • Exhibit 3: Telehealth Visits in the US (In Million) for the Years 2019 and 2020
  • Exhibit 4: Global Number of Telemedicine Patients (In Millions) for the Years 2016, 2018, 2020, 2023 & 2025
  • Pandemic Impact on eCOA, ePRO Market
  • COVID-19 Outbreak Compels Clinical Trials Industry to Move Towards ePRO
  • eCOA Solutions Help Address Hurdles Due to COVID-19 Pandemic
  • eCOA Playing a Part in Development of COVID-19 Vaccine
  • An Introduction to ePRO, E-Patient Diaries and eCOA
  • Global Market Prospects & Outlook
  • eCOA: The Largest Category
  • Competition
  • Exhibit 5: ePRO, E-Patient Diaries and eCOA - Global Key Competitors Percentage Market Share in 2022 (E)
  • Competitive Market Presence - Strong/Active/Niche for Players Worldwide in 2022 (E)
  • Recent Market Activity
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Digitalization of Healthcare Services and Rising Importance of Electronic Data Capture Technologies to Fuel Market Growth
  • Exhibit 6: Global Digital Health Market: Annual Revenues in US$ Million by Region/Country for 2020 and 2027
  • Growing Demand for Clinical Trials Drives Need for ePRO, ePatient Diaries, and eCOA Solutions
  • Exhibit 7: Industry-Funded, Interventional Clinical Trial Study Starts for the Period 2015-2022E
  • Exhibit 8: Clinical Trials in the US: % Change in Trial Starts by Therapy Area for 2020 Vs 2019
  • Exhibit 9: Breakdown of Trial Starts by Therapeutic Area (2021)
  • COVID-19 Pandemic Triggers Technology Adoption in Clinical Trials
  • Exhibit 10: Global Venture Funding (in $ Million) in Digital Health Solutions Targeting Clinical Trials for 2015-2020
  • Trends in Clinical Trials to Influence Market Demand
  • Clinical Trials Increasingly Embraced Technology Amid COVID-19 Pandemic
  • Shift Towards Decentralized/Virtual Clinical Trials to Boost Market Prospects
  • Exhibit 11: Global Virtual Clinical Trials Market Size (in US$ Billion) for the Years 2020, 2022, 2024 and 2026
  • Exhibit 12: Global Virtual Clinical Trials Market by Indication (in %) for 2022E
  • Decentralized Clinical Trials Driving Greater Demand for Patient-Centric Drug Development
  • Role of eCOA & ePRO in Enhancing Data Accuracy of Decentralized Clinical Trials
  • Growing Volumes of Data Generation in Decentralized Trials: A Challenge
  • Adoption of Digital Technologies in Contract Research Organizations Bodes Well for the Market
  • Exhibit 13: Global Contract Research Outsourcing Market Revenues (US$ Million) by Geographic Region for 2020 and 2027
  • Exhibit 14: Pharmaceutical R&D Spending Worldwide (USD Billion): 2015-2025
  • COVID-19 and Implications for Drug Development Regulations & Processes
  • Advances in ePRO Technologies Promise Better Clinical Decision Making in Healthcare Systems
  • Rise in Telemedicine Services Present Market Opportunities
  • Exhibit 15: Global Tele-Healthcare Market (In US$ Million) for Years 2020, 2022, 2024 and 2026
  • Growing Adoption of Mobile Technologies and BYOD Trend in Healthcare Industry Boosts Market Prospects
  • Exhibit 16: Smartphone Adoption Rate as Share of Total Population: 2016-2021
  • Exhibit 17: Mobile Device Use in Healthcare Settings: % Usage by Type of Mobile Device
  • Electronic Patient Record (ePRO) Solutions Emerge as Ideal Replacements for Paper-Based PRO systems
  • Major Benefits of ePRO over Paper Form in Clinical Trials
  • Delivering Better Data: A Key Benefit of ePRO
  • Factors Ensuring Success ePRO Implementations
  • ePatient-Reported Outcomes (PROs) Gain Importance in Oncology Studies
  • Key Technology Trends Impacting the ePRO in Clinical Trials
  • Data Integrity, Security & Privacy: Key Priorities for ePRO Solutions
  • Integrating AI Into ePRO Improves the Efficiency of ePRO Data Collection and Assessment
  • Electronic Clinical Outcome Assessment Solution (eCOA) Market: Poised for Growth
  • Exhibit 18: Global e-COA Market by Delivery Mode (in %) for 2022E
  • Exhibit 19: eCOA Usage by Clinical Trial Phase (in %) for 2021
  • Technological Trends Transforming eCOA Solutions Market
  • Future Trends in eCOA Market: A Review
  • eCOA Proves Beneficial in Addressing Clinical Trial Challenges During COVID-19 Pandemic
  • UAT, Challenges and Embedded UAT for eCOAs
  • Benefits of BYOD for eCOAs
  • E-Patient Diaries: Significant Advantages over Paper Diaries to Drive Market
  • Major Benefits of ePatient Diary
  • Increase in Healthcare Spending to Propel Demand
  • Exhibit 20: World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023
  • Exhibit 21: Spending as % of GDP by Country for 2019 and 2030
  • Increasing Burden of Chronic Diseases and Focus on Drug Development, Therapies and Vaccines Boosts Market
  • Exhibit 22: Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
  • Exhibit 23: Global Annual Medical Cost of CVD in US$ Billion (2010-2030)
  • Exhibit 24: Fatalities by Heart Conditions: Estimated Percentage Breakdown for Cardiovascular Disease, Ischemic Heart Disease, Stroke, and Others
  • Exhibit 25: World Diabetes and Population Statistics (2019, 2030 & 2045)
  • Aging World Population & COVID-19 Induced Re-Focus on Aging-In-Place to Drive Market Growth
  • Exhibit 26: Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World ePRO, E-Patient Diaries and eCOA Market Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027
  • Table 2: World Recent Past, Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 3: World 7-Year Perspective for ePRO, E-Patient Diaries and eCOA by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2021 & 2027
  • Table 4: World Recent Past, Current & Future Analysis for E-Clinical Outcome Assessments (eCOAs) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 5: World 7-Year Perspective for E-Clinical Outcome Assessments (eCOAs) by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2027
  • Table 6: World Recent Past, Current & Future Analysis for E-Patient Reported Outcomes (ePROs) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 7: World 7-Year Perspective for E-Patient Reported Outcomes (ePROs) by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2027
  • Table 8: World Recent Past, Current & Future Analysis for Clinician Reported Outcomes (ClinROs) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 9: World 7-Year Perspective for Clinician Reported Outcomes (ClinROs) by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2027
  • Table 10: World Recent Past, Current & Future Analysis for ePatient Diaries by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 11: World 7-Year Perspective for ePatient Diaries by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2027
  • Table 12: World Recent Past, Current & Future Analysis for Performance Outcomes (PerfOs) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 13: World 7-Year Perspective for Performance Outcomes (PerfOs) by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2027
  • Table 14: World Recent Past, Current & Future Analysis for Observer Reported Outcomes (ObsROs) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 15: World 7-Year Perspective for Observer Reported Outcomes (ObsROs) by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2027
  • Table 16: World Recent Past, Current & Future Analysis for Clinical Trial Sponsors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 17: World 7-Year Perspective for Clinical Trial Sponsors by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2027
  • Table 18: World Recent Past, Current & Future Analysis for Contract Research Organizations (CROs) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 19: World 7-Year Perspective for Contract Research Organizations (CROs) by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2027
  • Table 20: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 21: World 7-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2027
  • Table 22: World Recent Past, Current & Future Analysis for Academic Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 23: World 7-Year Perspective for Academic Institutes by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2027
  • Table 24: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 25: World 7-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2021 & 2027
III. MARKET ANALYSIS
UNITED STATES
  • ePRO, E-Patient Diaries and eCOA Market Presence - Strong/Active/Niche - Key Competitors in the United States for 2022 (E)
  • Market Analytics
  • Table 26: USA Recent Past, Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by Solution Type - E-Clinical Outcome Assessments (eCOAs), E-Patient Reported Outcomes (ePROs), Clinician Reported Outcomes (ClinROs), ePatient Diaries, Performance Outcomes (PerfOs) and Observer Reported Outcomes (ObsROs) - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 27: USA 7-Year Perspective for ePRO, E-Patient Diaries and eCOA by Solution Type - Percentage Breakdown of Value Revenues for E-Clinical Outcome Assessments (eCOAs), E-Patient Reported Outcomes (ePROs), Clinician Reported Outcomes (ClinROs), ePatient Diaries, Performance Outcomes (PerfOs) and Observer Reported Outcomes (ObsROs) for the Years 2021 & 2027
  • Table 28: USA Recent Past, Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by End-Use - Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 29: USA 7-Year Perspective for ePRO, E-Patient Diaries and eCOA by End-Use - Percentage Breakdown of Value Revenues for Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses for the Years 2021 & 2027
CANADA
  • Table 30: Canada Recent Past, Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by Solution Type - E-Clinical Outcome Assessments (eCOAs), E-Patient Reported Outcomes (ePROs), Clinician Reported Outcomes (ClinROs), ePatient Diaries, Performance Outcomes (PerfOs) and Observer Reported Outcomes (ObsROs) - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 31: Canada 7-Year Perspective for ePRO, E-Patient Diaries and eCOA by Solution Type - Percentage Breakdown of Value Revenues for E-Clinical Outcome Assessments (eCOAs), E-Patient Reported Outcomes (ePROs), Clinician Reported Outcomes (ClinROs), ePatient Diaries, Performance Outcomes (PerfOs) and Observer Reported Outcomes (ObsROs) for the Years 2021 & 2027
  • Table 32: Canada Recent Past, Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by End-Use - Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 33: Canada 7-Year Perspective for ePRO, E-Patient Diaries and eCOA by End-Use - Percentage Breakdown of Value Revenues for Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses for the Years 2021 & 2027
JAPAN
  • Table 34: Japan Recent Past, Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by Solution Type - E-Clinical Outcome Assessments (eCOAs), E-Patient Reported Outcomes (ePROs), Clinician Reported Outcomes (ClinROs), ePatient Diaries, Performance Outcomes (PerfOs) and Observer Reported Outcomes (ObsROs) - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 35: Japan 7-Year Perspective for ePRO, E-Patient Diaries and eCOA by Solution Type - Percentage Breakdown of Value Revenues for E-Clinical Outcome Assessments (eCOAs), E-Patient Reported Outcomes (ePROs), Clinician Reported Outcomes (ClinROs), ePatient Diaries, Performance Outcomes (PerfOs) and Observer Reported Outcomes (ObsROs) for the Years 2021 & 2027
  • Table 36: Japan Recent Past, Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by End-Use - Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 37: Japan 7-Year Perspective for ePRO, E-Patient Diaries and eCOA by End-Use - Percentage Breakdown of Value Revenues for Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses for the Years 2021 & 2027
CHINA
  • Table 38: China Recent Past, Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by Solution Type - E-Clinical Outcome Assessments (eCOAs), E-Patient Reported Outcomes (ePROs), Clinician Reported Outcomes (ClinROs), ePatient Diaries, Performance Outcomes (PerfOs) and Observer Reported Outcomes (ObsROs) - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 39: China 7-Year Perspective for ePRO, E-Patient Diaries and eCOA by Solution Type - Percentage Breakdown of Value Revenues for E-Clinical Outcome Assessments (eCOAs), E-Patient Reported Outcomes (ePROs), Clinician Reported Outcomes (ClinROs), ePatient Diaries, Performance Outcomes (PerfOs) and Observer Reported Outcomes (ObsROs) for the Years 2021 & 2027
  • Table 40: China Recent Past, Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by End-Use - Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 41: China 7-Year Perspective for ePRO, E-Patient Diaries and eCOA by End-Use - Percentage Breakdown of Value Revenues for Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses for the Years 2021 & 2027
EUROPE
  • ePRO, E-Patient Diaries and eCOA Market Presence - Strong/Active/Niche - Key Competitors in Europe for 2022 (E)
  • Market Analytics
  • Table 42: Europe Recent Past, Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 43: Europe 7-Year Perspective for ePRO, E-Patient Diaries and eCOA by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK and Rest of Europe Markets for Years 2021 & 2027
  • Table 44: Europe Recent Past, Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by Solution Type - E-Clinical Outcome Assessments (eCOAs), E-Patient Reported Outcomes (ePROs), Clinician Reported Outcomes (ClinROs), ePatient Diaries, Performance Outcomes (PerfOs) and Observer Reported Outcomes (ObsROs) - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 45: Europe 7-Year Perspective for ePRO, E-Patient Diaries and eCOA by Solution Type - Percentage Breakdown of Value Revenues for E-Clinical Outcome Assessments (eCOAs), E-Patient Reported Outcomes (ePROs), Clinician Reported Outcomes (ClinROs), ePatient Diaries, Performance Outcomes (PerfOs) and Observer Reported Outcomes (ObsROs) for the Years 2021 & 2027
  • Table 46: Europe Recent Past, Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by End-Use - Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 47: Europe 7-Year Perspective for ePRO, E-Patient Diaries and eCOA by End-Use - Percentage Breakdown of Value Revenues for Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses for the Years 2021 & 2027
FRANCE
  • Table 48: France Recent Past, Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by Solution Type - E-Clinical Outcome Assessments (eCOAs), E-Patient Reported Outcomes (ePROs), Clinician Reported Outcomes (ClinROs), ePatient Diaries, Performance Outcomes (PerfOs) and Observer Reported Outcomes (ObsROs) - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 49: France 7-Year Perspective for ePRO, E-Patient Diaries and eCOA by Solution Type - Percentage Breakdown of Value Revenues for E-Clinical Outcome Assessments (eCOAs), E-Patient Reported Outcomes (ePROs), Clinician Reported Outcomes (ClinROs), ePatient Diaries, Performance Outcomes (PerfOs) and Observer Reported Outcomes (ObsROs) for the Years 2021 & 2027
  • Table 50: France Recent Past, Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by End-Use - Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 51: France 7-Year Perspective for ePRO, E-Patient Diaries and eCOA by End-Use - Percentage Breakdown of Value Revenues for Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses for the Years 2021 & 2027
GERMANY
  • Table 52: Germany Recent Past, Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by Solution Type - E-Clinical Outcome Assessments (eCOAs), E-Patient Reported Outcomes (ePROs), Clinician Reported Outcomes (ClinROs), ePatient Diaries, Performance Outcomes (PerfOs) and Observer Reported Outcomes (ObsROs) - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 53: Germany 7-Year Perspective for ePRO, E-Patient Diaries and eCOA by Solution Type - Percentage Breakdown of Value Revenues for E-Clinical Outcome Assessments (eCOAs), E-Patient Reported Outcomes (ePROs), Clinician Reported Outcomes (ClinROs), ePatient Diaries, Performance Outcomes (PerfOs) and Observer Reported Outcomes (ObsROs) for the Years 2021 & 2027
  • Table 54: Germany Recent Past, Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by End-Use - Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 55: Germany 7-Year Perspective for ePRO, E-Patient Diaries and eCOA by End-Use - Percentage Breakdown of Value Revenues for Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses for the Years 2021 & 2027
ITALY
  • Table 56: Italy Recent Past, Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by Solution Type - E-Clinical Outcome Assessments (eCOAs), E-Patient Reported Outcomes (ePROs), Clinician Reported Outcomes (ClinROs), ePatient Diaries, Performance Outcomes (PerfOs) and Observer Reported Outcomes (ObsROs) - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 57: Italy 7-Year Perspective for ePRO, E-Patient Diaries and eCOA by Solution Type - Percentage Breakdown of Value Revenues for E-Clinical Outcome Assessments (eCOAs), E-Patient Reported Outcomes (ePROs), Clinician Reported Outcomes (ClinROs), ePatient Diaries, Performance Outcomes (PerfOs) and Observer Reported Outcomes (ObsROs) for the Years 2021 & 2027
  • Table 58: Italy Recent Past, Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by End-Use - Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 59: Italy 7-Year Perspective for ePRO, E-Patient Diaries and eCOA by End-Use - Percentage Breakdown of Value Revenues for Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses for the Years 2021 & 2027
UNITED KINGDOM
  • Table 60: UK Recent Past, Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by Solution Type - E-Clinical Outcome Assessments (eCOAs), E-Patient Reported Outcomes (ePROs), Clinician Reported Outcomes (ClinROs), ePatient Diaries, Performance Outcomes (PerfOs) and Observer Reported Outcomes (ObsROs) - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 61: UK 7-Year Perspective for ePRO, E-Patient Diaries and eCOA by Solution Type - Percentage Breakdown of Value Revenues for E-Clinical Outcome Assessments (eCOAs), E-Patient Reported Outcomes (ePROs), Clinician Reported Outcomes (ClinROs), ePatient Diaries, Performance Outcomes (PerfOs) and Observer Reported Outcomes (ObsROs) for the Years 2021 & 2027
  • Table 62: UK Recent Past, Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by End-Use - Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 63: UK 7-Year Perspective for ePRO, E-Patient Diaries and eCOA by End-Use - Percentage Breakdown of Value Revenues for Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses for the Years 2021 & 2027
REST OF EUROPE
  • Table 64: Rest of Europe Recent Past, Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by Solution Type - E-Clinical Outcome Assessments (eCOAs), E-Patient Reported Outcomes (ePROs), Clinician Reported Outcomes (ClinROs), ePatient Diaries, Performance Outcomes (PerfOs) and Observer Reported Outcomes (ObsROs) - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 65: Rest of Europe 7-Year Perspective for ePRO, E-Patient Diaries and eCOA by Solution Type - Percentage Breakdown of Value Revenues for E-Clinical Outcome Assessments (eCOAs), E-Patient Reported Outcomes (ePROs), Clinician Reported Outcomes (ClinROs), ePatient Diaries, Performance Outcomes (PerfOs) and Observer Reported Outcomes (ObsROs) for the Years 2021 & 2027
  • Table 66: Rest of Europe Recent Past, Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by End-Use - Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 67: Rest of Europe 7-Year Perspective for ePRO, E-Patient Diaries and eCOA by End-Use - Percentage Breakdown of Value Revenues for Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses for the Years 2021 & 2027
ASIA-PACIFIC
  • ePRO, E-Patient Diaries and eCOA Market Presence - Strong/Active/Niche - Key Competitors in Asia-Pacific for 2022 (E)
  • Market Analytics
  • Table 68: Asia-Pacific Recent Past, Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by Solution Type - E-Clinical Outcome Assessments (eCOAs), E-Patient Reported Outcomes (ePROs), Clinician Reported Outcomes (ClinROs), ePatient Diaries, Performance Outcomes (PerfOs) and Observer Reported Outcomes (ObsROs) - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 69: Asia-Pacific 7-Year Perspective for ePRO, E-Patient Diaries and eCOA by Solution Type - Percentage Breakdown of Value Revenues for E-Clinical Outcome Assessments (eCOAs), E-Patient Reported Outcomes (ePROs), Clinician Reported Outcomes (ClinROs), ePatient Diaries, Performance Outcomes (PerfOs) and Observer Reported Outcomes (ObsROs) for the Years 2021 & 2027
  • Table 70: Asia-Pacific Recent Past, Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by End-Use - Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 71: Asia-Pacific 7-Year Perspective for ePRO, E-Patient Diaries and eCOA by End-Use - Percentage Breakdown of Value Revenues for Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses for the Years 2021 & 2027
REST OF WORLD
  • Table 72: Rest of World Recent Past, Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by Solution Type - E-Clinical Outcome Assessments (eCOAs), E-Patient Reported Outcomes (ePROs), Clinician Reported Outcomes (ClinROs), ePatient Diaries, Performance Outcomes (PerfOs) and Observer Reported Outcomes (ObsROs) - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 73: Rest of World 7-Year Perspective for ePRO, E-Patient Diaries and eCOA by Solution Type - Percentage Breakdown of Value Revenues for E-Clinical Outcome Assessments (eCOAs), E-Patient Reported Outcomes (ePROs), Clinician Reported Outcomes (ClinROs), ePatient Diaries, Performance Outcomes (PerfOs) and Observer Reported Outcomes (ObsROs) for the Years 2021 & 2027
  • Table 74: Rest of World Recent Past, Current & Future Analysis for ePRO, E-Patient Diaries and eCOA by End-Use - Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 75: Rest of World 7-Year Perspective for ePRO, E-Patient Diaries and eCOA by End-Use - Percentage Breakdown of Value Revenues for Clinical Trial Sponsors, Contract Research Organizations (CROs), Hospitals, Academic Institutes and Other End-Uses for the Years 2021 & 2027
IV. COMPETITION
  • Total Companies Profiled: 75

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Anju Software, Inc.
  • ArisGlobal LLC
  • Castor EDC
  • Clario
  • Climedo Health GmbH
  • ClinCapture
  • Dassault Systèmes SE
  • eClinical Solutions LLC
  • ICON plc
  • IQVIA Holdings, Inc.
  • Kayentis, SAS
  • Medidata Solutions Inc.
  • Mednet
  • Signant Health
  • TransPerfect